For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress
Research To Practice | Oncology Videos · Dr. Neil Love
July 7, 20251h 29m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Anne Chiang, Ms Elizabeth Krueger, Ms Beth Sandy and Dr Erin Schenk, including the following topics:
- Introduction: Overview of Bispecific Antibodies (0:00)
- Biology of Small-Cell Lung Cancer (SCLC) and Review of Its Initial Management (13:37)
- Case: 63-year-old man — Ms Krueger (23:36)
- Current Role of Tarlatamab in Therapy for SCLC (33:40)
- Case: 70-year-old woman — Ms Sandy (43:41)
- Future Directions in the Management of SCLC (50:45)
- Case: 81-year-old man — Ms Krueger (1:01:24)
- Unique Considerations in SCLC Management (1:09:29)
- Case: 67-year-old woman — Ms Sandy (1:22:53)